Xiaolin Liang

Suggest Changes
Learn More
PURPOSE To fully characterize the risk of contralateral breast cancer (CBC) in patients with breast cancer with a family history who test negative for BRCA1 and BRCA2 mutations. PATIENTS AND(More)